Oncocyte Corp
IRVINE, CA · CIK 0001642380 · Medtech · Public
Precision diagnostic tests for oncology and transplantation based on molecular analysis
imdxinc.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $83M
- 9 Form D · Feb 2025
- 20 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,300,000 | |
| Private capital raised | Form D · SEC | $8,349,439 | |
| Private capital raised | Form D · SEC | $10,549,997 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $3,006,577 | |
| Private capital raised | Form D · SEC | $15,807,692 | |
| Private capital raised | Form D · SEC | $10,204,262 | |
| Private capital raised | Form D · SEC | $21,743,597 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1939 | Cutting Edge Spine, llc | — | $1.3M |
| 1940 | REFLEXION MEDICAL, INC. | — | $413M |
| 1941 | Conformal Medical, Inc. | — | $145M |
| 1942 | Oncocyte Corp | — | $83M |
| 1943 | MORPHIX TECHNOLOGIES, INC. | — | — |
| 1944 | Lungpacer Medical, Inc. | — | $133M |
| 1945 | ILLIONIX, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ronald AndrewsDirector · Executive Officer
- William AnnettDirector · Executive Officer
- Andrew ArnoDirector
- Andy ArnoDirector
- Don BaileyDirector
- Jennifer CarterDirector
- Karen ChapmanExecutive Officer
- Melinda GriffithDirector
- Andrea JamesExecutive Officer
- Alfred KingsleyDirector
- Andrew LastDirector
- Mitch LevineExecutive Officer
- Mitchell LevineExecutive Officer
- James LiuDirector · Executive Officer
- Kristine MechemExecutive Officer
- Aditya MohantyDirector
- Albert ParkerExecutive Officer
- Robert PeabodyDirector · Executive Officer
- Cavan RedmondDirector
- Joshua RiggsDirector · Executive Officer
- Douglas RossExecutive Officer
- Louis SilvermanDirector
- Russell SkibstedExecutive Officer
- Padmavathi SundarExecutive Officer
- Joseph WagnerDirector · Executive Officer
- Michael WestDirector
Patents
- Methods And Compositions For The Treatment And Diagnosis Of Cancerapplication
- Methods And Compositions For The Treatment And Diagnosis Of Bladder Cancerapplication
- Methods and Compositions for the Treatment and Diagnosis of Bladder Cancerapplication
- Methods and Compositions for the Treatment and Diagnosis of Cancerapplication
- Methods And Compositions For The Treatment And Diagnosis Of Cancerapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.